NASDAQ:MDWD

Mediwound Stock Insider Trading

etoro logo Buy MDWD
*Your capital is at risk
$14.12
+0.0200 (+0.142%)
At Close: Jul 31, 2026

MediWound Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 760.08K and sold 0 MDWD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 760.08K shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 18, 2026
Buy
Ordinary shares
Rubinstein Samuel
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Rubinstein Samuel
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Rubinstein Samuel
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Stock Option (right to buy ordinary shares)
Rubinstein Samuel
Director
Director 6 250
Value: $110.0K
Mar 18, 2026
Buy
Ordinary shares
Hess Shmuel
COO & Chief Commercial Officer
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Hess Shmuel
COO & Chief Commercial Officer
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Hess Shmuel
COO & Chief Commercial Officer
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Stock Option (right to buy ordinary shares)
Hess Shmuel
COO & Chief Commercial Officer
C-Suite Officer 32 000
Value: $260.1K
Mar 18, 2026
Buy
Stock Option (right to buy ordinary shares)
Hess Shmuel
COO & Chief Commercial Officer
C-Suite Officer 32 681
Value: $416.0K
Mar 18, 2026
Buy
Stock Option (right to buy ordinary shares)
Hess Shmuel
COO & Chief Commercial Officer
C-Suite Officer 24 000
Value: $445.0K
Mar 18, 2026
Buy
Stock Option (right to buy ordinary shares)
Hess Shmuel
COO & Chief Commercial Officer
C-Suite Officer 31 000
Value: $545.6K
Mar 18, 2026
Buy
Ordinary shares
Gonen Ofer
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Gonen Ofer
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Gonen Ofer
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Gonen Ofer
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary shares
Gonen Ofer
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Stock Option (right to buy ordinary shares)
Gonen Ofer
Chief Executive Officer
CEO / President 71 000
Value: $1.25M
Mar 18, 2026
Buy
Stock Option (right to buy ordinary shares)
Gonen Ofer
Chief Executive Officer
CEO / President 68 000
Value: $1.26M
Feb 11, 2026
Buy
Stock Option (right to buy ordinary shares)
Driver Vickie Rae
Director
Director 5 600
Value: $103.8K
Feb 11, 2026
Buy
Stock Option (right to buy ordinary shares)
Fox David Morton
Director
Director 5 600
Value: $103.8K
Feb 11, 2026
Buy
Stock Option (right to buy ordinary shares)
Wills Stephen T
Director
Director 5 600
Value: $103.8K
Feb 11, 2026
Buy
Stock Option (right to buy ordinary shares)
Rubinstein Samuel
Director
Director 5 600
Value: $103.8K
Mar 04, 2025
Buy
Stock Option (right to buy ordinary shares)
Klinger Ety
Chief Medical Officer
Officer 3 323
Value: $124.7K
Mar 04, 2025
Buy
Stock Option (right to buy ordinary shares)
Ben Yaakov Aya
Vp Clinical & Reg. Affairs
Officer 357
Value: $13.4K
Mar 04, 2025
Buy
Stock Option (right to buy ordinary shares)
Meyer Yaron
EVP, GC & Corp. Secretary
Officer 2 769
Value: $103.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MEDIWOUND LTD.
MediWound
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE